§
Luxuse
Patent Intelligence
Sign In
← Back to Patent Explorer
US4314987A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for diagnosing rheumatological diseases

Assignee: Rheumatology Diagnostics Laboratory
•
Filing: 1979-04-04
•
Granted: 1982-02-09
•
Expires: 1999-04-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for differential diagnosis of various rheumatological and arthritic diseases, all of which may yield similar antinuclear antibody test results. The process comprises a continuous sequence of tests on a single serum specimen to minimize and eliminate variations, thus providing accurate results. The process involves drawing a serum from a patient and first performing an antinuclear antibody test which is evaluated. If the evaluation is positive, then the particular type of positive indication is interpreted. If the interpretation reveals peripheral or speckled immunofluorescence, then a diagnosis of active Systemic Lupus Erythematosus (SLE), or mixed connective tissue disease (MCTD) are suggested, and automatically additional confirming tests will be performed as part of the process. These tests are the anti-DNA (Deoxyribonucleic Acid), the anti-ENA (extractable nuclear antigen). The test for the complement component C3 and a muscle disease test, called a creatine phosphokinase (CPK) which is a test for an enzyme contained in skeletal muscle. The results are compiled and reported in addition to reporting the degree of positivity by titer, which is the strength of a solution or the concentration of the antinuclear antibodies determined by a series of titrations or dilutions.

Inventors

  • 👤 Robert I. Morris
  • 👤 Allan L. Metzger
  • 👤 Arnold S. Weiss

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 20:07
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/564; G01N2800/00; G01N2800/10; G01N2800/101; G01N2800/102; G01N2800/104; Y; Y10; Y10S; Y10S436/00; Y10S436/821

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 97 words
A process for differential diagnosis of rheumatological diseases comprising: drawing a blood speciman; separating the serum to be tested from the blood specimen; reacting the serum with an antigen to produce antinuclear antibodies; labelling the antinuclear antibodies with a fluorescent material; determining whether the antinuclear antibody labelling for a positive immunofluorescent pattern has produced a homogeneous pattern, rim pattern, speckled pattern or nucleolar pattern; testing the same serum separated from the blood specimen in a continuous sequence for Systemic Lupus Erythematosus or Mixed Connective Tissue Disease if the pattern is a rim pattern or speckled pattern, respectively.
Claim 2
Dependent Claim 97 words
A process for differential diagnosis of rheumatological diseases comprising: drawing a blood speciman; separating the serum to be tested from the blood specimen; reacting the serum with an antigen to produce antinuclear antibodies; labelling the antinuclear antibodies with a fluorescent material; determining whether the antinuclear antibody labelling for a positive immunofluorescent pattern has produced a homogeneous pattern, rim pattern, speckled pattern or nucleolar pattern; testing the same serum separated from the blood specimen in a continuous sequence for Systemic Lupus Erythematosus or Mixed Connective Tissue Disease if the pattern is a rim pattern or speckled pattern, respectively.
Claim 3
Dependent Claim 22 words
The process according to claim 1 including: diluting the serum to determine titer if one of the positive immunofluorescent patterns is discovered.
Claim 4
Dependent Claim 46 words
The process according to claim 1 wherein a rim pattern is discovered including the steps of, reacting the serum sample with DNA labelled with a tracer element, such as radioactive iodine; counting the labelled serum with a radioactive counter to determine if anti-DNA antibodies are present.
Claim 5
Dependent Claim 20 words
The process according to claim 3 including the further step of testing the serum for complement component C 3 antigen.
Claim 6
Dependent Claim 54 words
The process according to claim 4 wherein the human complement of C 3 test includes the steps of preparing a semi-solid medium having anti-complement C 3 antibody; forming wells in said semi-solid body; filling said wells with serum samples; measuring the circular zone of precipitation to determine the diffusing antigen complement C 3 concentration.
Claim 7
Dependent Claim 23 words
The process according to claim 1 wherein a specified pattern is discovered including the step of testing the serum for anti-extractable nuclear antigens.
Claim 8
Dependent Claim 45 words
The process according to claim 6 including the steps of reacting the serum sample with a source of soluble nuclear proteins; reacting the first reactant with a source of SM and RNP antigens to detect the presence of either or both SM or RNP antibodies.
Claim 9
Dependent Claim 18 words
The process according to claim 6 including the step of testing the serum sample for creatine phosphokinase enzyme.

References Cited (Backward Citations)

US3897212A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-02-08 1985-08-10 1986-02-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-02-08 1989-08-10 1990-02-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-02-08 1993-08-10 1994-02-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag